The increased understanding of activation pathways and related ECD conformations may inspire the design of new molecules targeting the ECDECL interface
Research reviews also describe BPC-157s protective effects in models involving NSAID-related gastrointestinal lesions, alcohol-related injury, perforated stomach lesions, esophagitis, fistula healing, intestinal inflammation, and other GI injury models
it's a human truth, really
Other warnings involve severe gastrointestinal adverse reactions, delayed gastric emptying, pancreatitis, gallbladder problems, acute kidney injury related to dehydration, increased heart rate, hypoglycemia when used with certain diabetes medications, and suicidal behavior or thinking